Redefine Patient Care
Is your practice leading the way with innovative treatment options?
Tackle Pain and Aesthetic Concerns FAST
Learn about non-surgical, low-risk treatment options that allow you to stay active.
Set your practice apart by offering the regenerative solutions your patients are seeking.
The FDA Approved Focused Shock Wave is the next generation of ESWT Extracorporeal Shock Wave Treatment with patented focused “Cylindrical Source“ Technology available from CuraMedix. This unique device leads the industry in innovation and performance for the treatment of pain associated with chronic proximal plantar fasciitis.
From STORZ Medical: The Chattanooga Intelect F-SW USA is an alternative tradename for the same device, the STORZ DUOLITH SD1. The clinical data presented in PMA approval P080028 applies to both tradenames.
This Focused Shock Wave device uses an electromagnetically generated shock wave produced within a hand-held applicator (F-SW Hand piece). The shock wave is generated by discharging a high voltage capacitor located in the control unit into a cylindrically shaped coil system in the handpiece which is surrounded by a cylindrical metallic membrane. The transient magnetic field produced by the coil induces eddy currents in the metal membrane, causing it to repel from the coil, producing a pressure wave. The membrane is immersed in water and the pressure wave produced by the membrane propagates through the water to a concentric parabolic reflector, where it is reflected to a focal point outside of the handpiece in front of the reflector.
With its progressive technological advancements, Extracorporeal Pulse Activation Technology (EPAT/ESWT) delivers an evidence-based*, non-surgical solution for patients suffering from chronic heel pain. It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.
Health care professionals are using EPAT/ESWT to successfully treat acute or chronic musculoskeletal pain and/or
Check out the study published in The Journal of Bone Joint Surgery “Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.”
The best way to advance patient care for your practice is looking to the evidence that’s available for new technologies and protocols. CuraMedix solutions like EPAT(R) are backed by clinical studies and are evidence-based; whereas similar competing technologies cannot make this claim.